1387. Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment.
Paik JH1, Go H, Nam SJ, Kim TM, Heo DS, Kim CW, Jeon YK.
Leuk Lymphoma. 2013 Sep;54(9):1934-41. doi: 10.3109/10428194.2012.762511. Epub 2013 Feb 16.Link
1386. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
1385. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
Jang JY1, Jeon YK, Lee CE, Kim CW.
Int J Oncol. 2013 Feb;42(2):574-82. doi: 10.3892/ijo.2012.1736. Epub 2012 Dec 13.Link
1384. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
Jang JY1, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW.
Exp Mol Med. 2013 Jan 10;45:e3. doi: 10.1038/emm.2013.1.Link
1383. Sequence-Dependent Radiosensitization of Histone Deacetylase Inhibitors Trichostatin A and SK-7041.
Kim JH1, Kim IH2, Shin JH1, Kim HJ1, Kim IA3.
Cancer Res Treat. 2013 Dec;45(4):334-42. doi: 10.4143/crt.2013.45.4.334. Epub 2013 Dec 31.Link
1382. RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
Shin DY1, Kim I, Kim JH, Lee YG, Kang EJ, Cho HJ, Lee KH, Kim HJ, Park EH, Lee JE, Bae JY, See CJ, Yoon SS, Park SS, Han KS, Park MH, Hong YC, Park S, Kim BK.
Acta Haematol. 2013;129(3):137-45. doi: 10.1159/000343273. Epub 2012 Nov 30.Link
1381. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
Lee YG1, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Park J, Lee JH, Kim SY, Lee HG, Kim YK, Kim HJ; Korean Society of Haematology AML/MDS working party.
1380. Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis.
Bae JY1, Kim JW, Kim I.
Oncol Rep. 2013 Jul;30(1):485-91. doi: 10.3892/or.2013.2444. Epub 2013 May 9.Link
1379. DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.
Lee HE1, Han N, Kim MA, Lee HS, Yang HK, Lee BL, Kim WH.
Pathobiology. 2014;81(1):25-35. doi: 10.1159/000351072. Epub 2013 Aug 21.Link
1378. In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry.
Kim MA1, Jung JE, Lee HE, Yang HK, Kim WH.
Hum Pathol. 2013 Apr;44(4):487-94. doi: 10.1016/j.humpath.2012.06.022. Epub 2012 Oct 16.Link